1542 related articles for article (PubMed ID: 33977279)
1. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
[TBL] [Abstract][Full Text] [Related]
2. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.
Mahida RY; Chotalia M; Alderman J; Patel C; Hayden A; Desai R; Beesley E; Crowley LE; Soltan M; Bangash M; Parekh D; Patel J; Thickett DR
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33257441
[TBL] [Abstract][Full Text] [Related]
3. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Cerro Chiang G; Kassar AG; Patel N; Green CER; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
Cell Rep; 2021 Jan; 34(1):108590. PubMed ID: 33357411
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
[TBL] [Abstract][Full Text] [Related]
5. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.
Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N
Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033
[No Abstract] [Full Text] [Related]
6. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation.
Bonnet B; Cosme J; Dupuis C; Coupez E; Adda M; Calvet L; Fabre L; Saint-Sardos P; Bereiziat M; Vidal M; Laurichesse H; Souweine B; Evrard B
EBioMedicine; 2021 Nov; 73():103622. PubMed ID: 34678611
[TBL] [Abstract][Full Text] [Related]
7. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.
Kosyreva A; Dzhalilova D; Lokhonina A; Vishnyakova P; Fatkhudinov T
Front Immunol; 2021; 12():682871. PubMed ID: 34040616
[TBL] [Abstract][Full Text] [Related]
8. Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning.
Xu W; Sun NN; Gao HN; Chen ZY; Yang Y; Ju B; Tang LL
Sci Rep; 2021 Feb; 11(1):2933. PubMed ID: 33536460
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.
Buchholtz ML; Arend FM; Eichhorn P; Weigand M; Kleinhempel A; Häusler K; Bruegel M; Holdt LM; Teupser D
PLoS One; 2021; 16(5):e0251587. PubMed ID: 33984048
[TBL] [Abstract][Full Text] [Related]
10. A distinct innate immune signature marks progression from mild to severe COVID-19.
Chevrier S; Zurbuchen Y; Cervia C; Adamo S; Raeber ME; de Souza N; Sivapatham S; Jacobs A; Bachli E; Rudiger A; Stüssi-Helbling M; Huber LC; Schaer DJ; Nilsson J; Boyman O; Bodenmiller B
Cell Rep Med; 2021 Jan; 2(1):100166. PubMed ID: 33521697
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
Reizine F; Lesouhaitier M; Gregoire M; Pinceaux K; Gacouin A; Maamar A; Painvin B; Camus C; Le Tulzo Y; Tattevin P; Revest M; Le Bot A; Ballerie A; Cador-Rousseau B; Lederlin M; Lebouvier T; Launey Y; Latour M; Verdy C; Rossille D; Le Gallou S; Dulong J; Moreau C; Bendavid C; Roussel M; Cogne M; Tarte K; Tadié JM
J Clin Immunol; 2021 Apr; 41(3):515-525. PubMed ID: 33387156
[TBL] [Abstract][Full Text] [Related]
12. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
[TBL] [Abstract][Full Text] [Related]
13. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
Juanes-Velasco P; Landeira-Viñuela A; García-Vaquero ML; Lecrevisse Q; Herrero R; Ferruelo A; Góngora R; Corrales F; Rivas JL; Lorente JA; Hernández ÁP; Fuentes M
Front Immunol; 2022; 13():732197. PubMed ID: 35154090
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Interferon- γ Rescues Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) Function in a COVID-19 Patient With ARDS and Superinfection With Multiple MDR 4MRGN Bacterial Strains.
Grimm C; Dickel S; Grundmann J; Payen D; Schanz J; Zautner AE; Tampe B; Moerer O; Winkler MS
Front Immunol; 2021; 12():753849. PubMed ID: 34790197
[TBL] [Abstract][Full Text] [Related]
16. Histopathological features in fatal COVID-19 acute respiratory distress syndrome.
Merdji H; Mayeur S; Schenck M; Oulehri W; Clere-Jehl R; Cunat S; Herbrecht JE; Janssen-Langenstein R; Nicolae A; Helms J; Meziani F; Chenard MP;
Med Intensiva (Engl Ed); 2021; 45(5):261-270. PubMed ID: 34059216
[TBL] [Abstract][Full Text] [Related]
17. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.
Venet F; Cour M; Rimmelé T; Viel S; Yonis H; Coudereau R; Amaz C; Abraham P; Monard C; Casalegno JS; Brengel-Pesce K; Lukaszewicz AC; Argaud L; Monneret G;
Crit Care; 2021 Apr; 25(1):140. PubMed ID: 33845874
[TBL] [Abstract][Full Text] [Related]
19. CD169 Defines Activated CD14
Affandi AJ; Olesek K; Grabowska J; Nijen Twilhaar MK; Rodríguez E; Saris A; Zwart ES; Nossent EJ; Kalay H; de Kok M; Kazemier G; Stöckl J; van den Eertwegh AJM; de Gruijl TD; Garcia-Vallejo JJ; Storm G; van Kooyk Y; den Haan JMM
Front Immunol; 2021; 12():697840. PubMed ID: 34394090
[TBL] [Abstract][Full Text] [Related]
20. Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes.
Alzaid F; Julla JB; Diedisheim M; Potier C; Potier L; Velho G; Gaborit B; Manivet P; Germain S; Vidal-Trecan T; Roussel R; Riveline JP; Dalmas E; Venteclef N; Gautier JF
EMBO Mol Med; 2020 Oct; 12(10):e13038. PubMed ID: 32816392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
